Relative Bioavailability Study for GSK1838262 (Gabapentin Enacarbil)

Clinical trial NCT00833391 · COMPLETED

Trial details

NCT number: NCT00833391
Sponsor: XenoPort, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pharmacokinetics Healthy Volunteer

Start date: 2009-01-01
Primary completion: 2009-03-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.